Literature DB >> 29302716

Role of sacral neuromodulation in modern urogynaecology practice: a review of recent literature.

Samina Tahseen1.   

Abstract

Sacral neuromodulation (SNM) offers promise in the therapy of many pelvic floor disorders. This innovative treatment has slowly gained popularity. A review of recent literature is presented in relation to its efficacy and complications in various pelvic floor conditions: overactive bladder and urge urinary incontinence, chronic urinary retention, painful bladder syndrome, pelvic pain and double incontinence. It is a minimally invasive, completely reversible safe procedure with good long-term outcomes. However, the treatment is costly, the revision rate is high and patients require life-long follow-up. SNM should always be considered in suitable patients before offering bladder augmentation procedures or urinary diversion or permanent catheterization for bladder dysfunction. SNM should also be considered in patients with double incontinence, after discussion in a urogynaecology/colorectal multidisciplinary team.

Entities:  

Keywords:  Bladder pain; Chronic urinary retention; Double incontinence; Overactive bladder symptoms; Sacral nerve stimulation; Urinary incontinence

Mesh:

Year:  2018        PMID: 29302716     DOI: 10.1007/s00192-017-3546-6

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  80 in total

1.  Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group.

Authors:  R A Schmidt; U Jonas; K A Oleson; R A Janknegt; M M Hassouna; S W Siegel; P E van Kerrebroeck
Journal:  J Urol       Date:  1999-08       Impact factor: 7.450

2.  Sacral neuromodulation for nonobstructive urinary retention: a meta-analysis.

Authors:  Carey Gross; Mounira Habli; Christopher Lindsell; Mary South
Journal:  Female Pelvic Med Reconstr Surg       Date:  2010-07       Impact factor: 2.091

3.  Bladder pacemaker: scientific basis and clinical future.

Authors:  E A Tanagho; R A Schmidt
Journal:  Urology       Date:  1982-12       Impact factor: 2.649

Review 4.  Results of sacral nerve neuromodulation for double incontinence in adults.

Authors:  M Chodez; B Trilling; C Thuillier; B Boillot; S Barbois; J-L Faucheron
Journal:  Tech Coloproctol       Date:  2014-11-08       Impact factor: 3.781

5.  Efficacy of sacral neuromodulation in treatment of bladder pain syndrome: long-term follow-up.

Authors:  Yahya Q Ghazwani; Mohamed S Elkelini; Magdy M Hassouna
Journal:  Neurourol Urodyn       Date:  2011-05-06       Impact factor: 2.696

Review 6.  Efficacy and adverse events of sacral nerve stimulation for overactive bladder: A systematic review.

Authors:  Nazema Y Siddiqui; Jennifer M Wu; Cindy L Amundsen
Journal:  Neurourol Urodyn       Date:  2010       Impact factor: 2.696

7.  Long-term outcome of the use of intravesical botulinum toxin for the treatment of overactive bladder (OAB).

Authors:  Amar Mohee; Ayisha Khan; Neil Harris; Ian Eardley
Journal:  BJU Int       Date:  2012-06-06       Impact factor: 5.588

8.  A prospective randomized trial comparing the 1-stage with the 2-stage implantation of a pulse generator in patients with pelvic floor dysfunction selected for sacral nerve stimulation.

Authors:  K Everaert; W Kerckhaert; H Caluwaerts; M Audenaert; H Vereecke; G De Cuypere; A Boelaert; U Van den Hombergh; W Oosterlinck
Journal:  Eur Urol       Date:  2004-05       Impact factor: 20.096

Review 9.  Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal.

Authors:  Joop P van de Merwe; Jørgen Nordling; Pierre Bouchelouche; Kirsten Bouchelouche; Mauro Cervigni; L Kurosch Daha; Suzy Elneil; Magnus Fall; Gero Hohlbrugger; Paul Irwin; Svend Mortensen; Arndt van Ophoven; John L Osborne; Ralph Peeker; Benedikte Richter; Claus Riedl; Jukka Sairanen; Martina Tinzl; Jean-Jacques Wyndaele
Journal:  Eur Urol       Date:  2007-09-20       Impact factor: 20.096

10.  Sacral neuromodulation for bowel dysfunction: a consensus statement from the Italian group.

Authors:  E Falletto; E Ganio; G Naldini; C Ratto; D F Altomare
Journal:  Tech Coloproctol       Date:  2013-04-06       Impact factor: 3.781

View more
  4 in total

Review 1.  Neural engineering: the process, applications, and its role in the future of medicine.

Authors:  Evon S Ereifej; Courtney E Shell; Jonathon S Schofield; Hamid Charkhkar; Ivana Cuberovic; Alan D Dorval; Emily L Graczyk; Takashi D Y Kozai; Kevin J Otto; Dustin J Tyler; Cristin G Welle; Alik S Widge; José Zariffa; Chet T Moritz; Dennis J Bourbeau; Paul D Marasco
Journal:  J Neural Eng       Date:  2019-11-12       Impact factor: 5.379

Review 2.  Electrical stimulation for neuroregeneration in urology: a new therapeutic paradigm.

Authors:  Brian M Balog; Kangli Deng; Vinod Labhasetwar; Kathryn J Jones; Margot S Damaser
Journal:  Curr Opin Urol       Date:  2019-07       Impact factor: 2.309

Review 3.  Neuromodulation - a therapeutic option for refractory overactive bladder. A recent literature review.

Authors:  Jacek K Szymański; Aneta Słabuszewska-Jóźwiak; Kornelia Zaręba; Grzegorz Jakiel
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2019-05-23       Impact factor: 1.195

4.  Long-term Outcomes of Sacral Nerve Stimulation in Pelvic Floor Dysfunctions.

Authors:  David Hernández-Hernández; Bárbara Padilla-Fernández; Milagros Castro Romera; Stephany Hess Medler; David Castro-Díaz
Journal:  Int Neurourol J       Date:  2021-01-27       Impact factor: 2.835

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.